Safety of nevirapine compared to abacavir on a background of zidovudine/lamivudine as first-line antiretroviral therapy: a randomised double-blind trial conducted in Uganda.

Citation

13th Conference on Retroviruses and Opportunistic Infections, Denver, USA, 5-9 February 2006: Abstract 109LB.

Safety of nevirapine compared to abacavir on a background of zidovudine/lamivudine as first-line antiretroviral therapy: a randomised double-blind trial conducted in Uganda.

Published 1 January 2006